Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 20 May 2026, 11:41AM

Asian countries tighten precautions against Ebola after WHO declaration

Business Standard

Several govts have expanded screening and reporting requirements for travelers arriving from affected countries, though officials say no cases have been publicly confirmed in Asia

WHO-Imperial College analysis suggests Congo Ebola outbreak undercounted

Business Standard | 20 May 2026, 09:53AM

Pharmaceuticals & Biotech.

SECTOR | 19 May 2026, 02:26PM

Ebola outbreak in Congo kills 131, over 500 suspected cases reported

Business Standard

At least 131 deaths and over 500 suspected cases have been reported in the ongoing Ebola outbreak in eastern Congo, the Congolese health ministry said Tuesday as details emerged about the government's delayed response. Samuel Roger Kamba, the minister of public health, said: "513 suspected cases and 131 deaths have been recorded in the affected areas." "These are suspected deaths, and investigations are underway to determine which ones are actually linked to the disease." The World Health Organisation (WHO) on Sunday declared the Ebola outbreak a public health emergency of international concern. Health authorities say the current outbreak, first confirmed on Friday, is caused by the Bundibugyo virus, a rare variant of the Ebola disease that has no approved therapeutics or vaccines. Although more than 20 Ebola outbreaks have taken place in Congo and Uganda, this is only the third time that the Bundibugyo virus has been detected. Cases have now been confirmed in Bunia, North Kivu's

Congo Ebola outbreak timeline: How the deadly virus spread across borders

Business Line | 19 May 2026, 08:00AM 5 more

Pharmaceuticals & Biotech.

SECTOR | 18 May 2026

Rare Ebola's silent spread in Congo exposes gaps in surveillance system

Business Standard

About 350 suspected cases and 91 deaths have been reported in northeastern Congo, the country's health minister Roger Kamba said on Sunday

Pharmaceuticals & Biotech.

SECTOR | 17 May 2026

WHO declares global health emergency over Ebola outbreak in Congo, Uganda

Business Standard

WHO Director-General Tedros Adhanom Ghebreyesus declared the Ebola disease outbreak in Congo and Uganda a public health emergency of international concern on Sunday after more than 300 suspected cases and 88 deaths. In a post on X, the World Health Organisation said the outbreak does not meet the criteria of a pandemic emergency like the COVID-19 pandemic, and advised against the closure of international borders. Ebola is highly contagious and can be contracted via bodily fluids such as vomit, blood or semen. The disease it causes is rare, but severe and often fatal. Health authorities have confirmed the current outbreak is caused by the Bundibugyo virus, a rare variant of the Ebola disease that has no approved therapeutics or vaccines. Although more than 20 Ebola outbreaks have taken place in Congo and Uganda, this is only the third time the Bundibugyo virus has been reported. Congo accounts for all except two of the cases, both of which were reported in neighbouring Uganda, the W

Pharmaceuticals & Biotech.

SECTOR | 16 May 2026

Rare Ebola virus strain with no approved vaccine kills dozens in Congo

Business Standard

About 246 suspected cases and 65 deaths have been reported mainly in Mongbwalu and Rwampara health zones in Ituri province, near the Ugandan border, in Democratic Republic of Congo

Ebola's Africa spread tests global response after aid cuts

Business Line | 16 May 2026

Pharmaceuticals & Biotech.

SECTOR | 05 May 2026

Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160

Business Line

Biocon's Mazumdar-Shaw sets out 5-year succession plan, names niece Claire as successor

Business Line | 05 May 2026

Pharmaceuticals & Biotech.

SECTOR | 28 Apr 2026

Toronto HIV patients in rare remission list after bone marrow transplant

Business Standard

A Toronto man living with HIV for 27 years is in sustained remission after a bone marrow transplant using HIV-resistant donor cells, according to University Health Network clinicians

Pharmaceuticals & Biotech.

SECTOR | 22 Apr 2026

Medical device industry calls for discussion on product mark-ups

Business Line

Fair pricing will reduce insurance premiums and widen coverage, says AiMed, on reining in hospital bills

Device makers pitch fair pricing model as MRP distortions draw scrutiny

Business Standard | 22 Apr 2026

Pharmaceuticals & Biotech.

SECTOR | 21 Apr 2026, 12:00AM

India Pharma Exports Crash 23% in March 2026 – 5 Year Low; Logistics Shock, Not Demand Reset

Pharmaceuticals & Biotech.

Deven Choksey

India's pharmaceutical exports declined sharply by 23.17% YoY in March 2026 to USD 2.83 billion as compared to USD 3.68 billion in March 2025, marking the steepest monthly contraction in over five years and the worst since the COVID-led decline of March 2020.

Pharmaceuticals & Biotech.

SECTOR | 15 Apr 2026

Japanese medical devices firm Create Medic plans to expand India operations

Business Line

Medical devices firm to open sales office in Chennai and other cities; targets 100 crore revenue from the Indian market